GlassScriptPhysician profile
Megan Macleod
NPI 1770057283
$858.09
in general payments reported to CMS, 2019-2025
11 companies · $30.97 in 2025
The $30.97 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2024: $704 · 2025: $30.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723 · Education: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.80 |
| Education | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $141.19 | 2024 | Azstarys |
| Vanda Pharmaceuticals INC. | $140.01 | 2024 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $116.09 | 2022-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $104.38 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Teva Pharmaceuticals USA, INC. | $104.32 | 2024 | Austedo Xr, Uzedy |
| Indivior INC. | $99.15 | 2024 | Sublocade |
| Abbvie INC. | $74.34 | 2022-2024 | |
| Lundbeck LLC | $32.47 | 2022 | |
| Braeburn INC. | $18.09 | 2024 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.49 | 2022 | |
| Axsome Therapeutics, INC. | $13.56 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Macleod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.